Delivery Order SPE2DB22D3501-SPE2DB26FTJ56
- Not listed
- The Defense Logistics Agency awarded a $1,420.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28 units. This non-set-aside contract is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling immediate medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.56 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count), a hormonal contraceptive medication. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location....
- The Defense Logistics Agency awarded a $30,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561327936 Drospirenone-EE 3-0.03 mg tablets. The delivery order was issued against an existing prime vendor contract vehicle to provide 28 count packages of the specified pharmaceutical product. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required between June 23 and June 26, 2023. No set aside designation...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,756.98 order is for the delivery of 4563715937 - DROSPIRENONE-EE 3-0.02 MG TAB 28S, a pharmaceutical product, to be delivered by February 21, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its Corporate Office division in...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,622.76 firm fixed-price delivery order is for the supply of DROSPIRENONE-EE 3-0.02 MG TAB 28S pharmaceutical products, with a period of performance through January 14, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- This is a $1,353.40 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the provision of 4563561688 ! DROSPIRENONE-EE 3-0.02 MG TAB 28S, a pharmaceutical product. The delivery order is being issued under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp as the sole awardee, with a potential value of up to $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a delivery order valued at $1,861.20 to AmerisourceBergen Drug Corp for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, issued on September 29, 2025, with a completion date of September 30, 2025, represents a non-competitive set-aside contract supporting the military's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $47,164.04 and a completion date of September 8, 2025. The award was made through open competition with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Cryselle-28 tablets, a birth control medication, with a ceiling value of $5,708.05. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTJ56Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,397.64 and employs firm fixed pricing, with an ultimate completion date of November 4, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other federal agencies. The company's contract portfolio demonstrates extensive capability in fulfilling diverse medical procurement requirements, from specialty medications and vaccines to generic pharmaceuticals, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/3/25 |